Aytu Biopharma, Inc (AYTU): Total Assets
$105.01M
As of 2026-06-30
-8.4%
3-year compound annual growth
-16.9%
5-year compound annual growth
+15.7%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $105.01M | -15.4% | 2026-09-22, Balance as of period end |
| 2025-06-30 | $124.18M | +5.2% | 2026-09-22, Balance as of period end |
| 2024-06-30 | $118.09M | -13.5% | 2025-09-23, Balance as of period end |
| 2023-06-30 | $136.46M | -0.8% | 2024-09-26, Balance as of period end |
| 2022-06-30 | $137.62M | -48.2% | 2023-10-12, Balance as of period end |
| 2021-06-30 | $265.67M | +73.3% | 2022-09-27, Balance as of period end |
| 2020-06-30 | $153.29M | +341.5% | 2021-09-28, Balance as of period end |
| 2019-06-30 | $34.72M | +64.9% | 2020-10-06, Balance as of period end |
| 2018-06-30 | $21.06M | +40.4% | 2019-09-26, Balance as of period end |
| 2017-06-30 | $15.00M | -38.4% | 2018-09-06, Balance as of period end |
| 2016-06-30 | $24.34M | +33.9% | 2017-08-31, Balance as of period end |
| 2015-06-30 | $18.19M | +51.3% | 2016-09-01, Balance as of period end |
| 2014-06-30 | $12.02M | n/a | 2015-09-28, Balance as of period end |
| 2013-08-31 | $9.7K | -23.5% | 2014-11-26, Balance as of period end |
| 2012-08-31 | $12.6K | -44.6% | 2014-11-26, Balance as of period end |
| 2011-08-31 | $22.8K | n/a | 2012-11-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Aytu Biopharma, Inc (AYTU) | 2026-06-30 | $105.01M | -15.4% |
| Nektar Therapeutics (NKTR) | 2025-12-31 | $280.41M | -7.7% |
| Journey Medical Corp (DERM) | 2025-12-31 | $94.59M | +17.9% |
| Agios Pharmaceuticals, Inc. (AGIO) | 2025-12-31 | $1.30B | -22.0% |
| Q32 Bio Inc. (QTTB) | 2025-12-31 | $61.78M | -33.1% |
| Tango Therapeutics, Inc. (TNGX) | 2025-12-31 | $398.69M | +26.0% |
| Nuvation Bio Inc. (NUVB) | 2025-12-31 | $594.82M | +10.0% |
| Fortress Biotech, Inc. (FBIO) | 2025-12-31 | $185.55M | +28.7% |
| Ocular Therapeutix, Inc (OCUL) | 2025-12-31 | $808.06M | +76.5% |
Compare AYTU, NKTR, DERM, AGIO side by side · Screen every company in Pharmaceutical Preparations ↗